Phone: 905-296-6460 | Email: firstname.lastname@example.org
We are testing the effect of a comprehensive virtual heart failure (HF) transitional care program on clinical outcomes, patient-reported health status, medication optimization, and healthcare utilization outcomes, relative to routine care of HF patients.
Aim 1: Test the effect of virtual HF clinics relative to routine care on a composite of patient-reported health status*
Aim 2: Test the effect of virtual HF clinics relative to routine care on the use of guideline-directed medical therapy (GDMT) and secondary clinical outcomes.
*as measured by the Kansas City Cardiomyopathy Questionnaire and Days Alive and Out of Hospital.
Randomized controlled trial
Harriette Van Spall is a Scientist for the Arrhythmia and Heart Failure research program and the Knowledge Translation and Health Systems program at PHRI, an Associate Professor, Department of Medicine (cardiology) at McMaster University. Her research, supported by CIHR and the Ministry of Health, is in quality of care and outcomes, knowledge translation, and health systems improvement pertaining to heart failure. She has won several research awards, and her work has been published in high-impact medical journals, including JAMA, Lancet, Circulation, and Annals of Internal Medicine.
She earned her Doctor of Medicine degree from the University of Toronto, and a Master of Public Health degree from the Harvard School of Public Health. She completed postgraduate training in Internal Medicine, Cardiology, and Echocardiography at the University of Toronto.
Mohamed Bella Jalloh is a research fellow at PHRI under the supervision of PHRI Scientist Harriette Van Spall. His main focus will include clinical trial methodology and implementation science. He will be involved in a multi-centre randomized controlled trial in heart failure.
Mohamed earned his medical degree from the University of Sierra Leone and a Master of Science from the University of Oxford. Previously, he was a global health scholar at Oxford, where he supported AMR and pandemic preparedness-focused global health initiatives.
Sumathy Rangarajan has been Program Director, Global Health, since 2016, preceded by many years’ service at PHRI in other roles. She oversees the PURE study team, as well as the INVICTUS rheumatic AF treatment trial, the CANPWR pediatric weight management registry, and others.
She holds both a Bachelor of Science Degree and a Master of Science degree from Pune University in India.
Divya Pattath has been with the Global Health team at PHRI since 2013, and has experience with managing large, international investigator-initiated clinical trials, observational studies and registries.
Divya holds a Masters Degree in Industrial Biotechnology and Enterprise from University of Bath, UK and Applied Clinical Research Certificate from McMaster University.
Back To Top